Alan Naylor is a medicinal chemist with over 30 years’ experience in Research and Development within GlaxoSmithKline. He previously held the position of Vice President and Director of Medicinal Chemistry within the GSK Drug Discovery organization and played a major role in the discovery of over 30 development compounds. He is a co-inventor of Serevent, a major advance in the treatment of asthma. Since retiring from GlaxoSmithKline in July 2008 Alan has been an independent consultant providing scientific and strategic advice and analysis to major pharma, biotechnology companies, academic groups, capital investment companies and funding bodies on a variety of issues within the drug discovery and healthcare sector.